188 related articles for article (PubMed ID: 21839732)
1. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).
Okamura Y; Yokoi H
Clin Chim Acta; 2011 Nov; 412(23-24):2157-61. PubMed ID: 21839732
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges.
Mussap M; Puxeddu E; Burrai P; Noto A; Cibecchini F; Testa M; Puddu M; Ottonello G; Dessì A; Irmesi R; Gassa ED; Fanni C; Fanos V
J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):51-3. PubMed ID: 23025769
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
[TBL] [Abstract][Full Text] [Related]
4. Presepsin (sCD14-ST), an innate immune response marker in sepsis.
Chenevier-Gobeaux C; Borderie D; Weiss N; Mallet-Coste T; Claessens YE
Clin Chim Acta; 2015 Oct; 450():97-103. PubMed ID: 26164388
[TBL] [Abstract][Full Text] [Related]
5. Determination of reference interval for presepsin, an early marker for sepsis.
Giavarina D; Carta M
Biochem Med (Zagreb); 2015; 25(1):64-8. PubMed ID: 25672468
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.
Mussap M; Noto A; Fravega M; Fanos V
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():12-4. PubMed ID: 21740312
[TBL] [Abstract][Full Text] [Related]
7. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department.
Liu B; Yin Q; Chen YX; Zhao YZ; Li CS
Respir Med; 2014 Aug; 108(8):1204-13. PubMed ID: 24931899
[TBL] [Abstract][Full Text] [Related]
8. Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis.
Sato M; Takahashi G; Shibata S; Onodera M; Suzuki Y; Inoue Y; Endo S
PLoS One; 2015; 10(12):e0143971. PubMed ID: 26623644
[TBL] [Abstract][Full Text] [Related]
9. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?
Chenevier-Gobeaux C; Trabattoni E; Roelens M; Borderie D; Claessens YE
Clin Chim Acta; 2014 Jan; 427():34-6. PubMed ID: 24076253
[TBL] [Abstract][Full Text] [Related]
10. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients.
Shirakawa K; Naitou K; Hirose J; Takahashi T; Furusako S
Clin Chem Lab Med; 2011 May; 49(5):937-9. PubMed ID: 21345045
[No Abstract] [Full Text] [Related]
11. Development of a newly immunoassay specific for mouse presepsin (sCD14-ST).
Takahashi G; Hoshikawa K; Suzuki R; Sato K; Hoshi S; Yoshinao D; Shirakawa K
Sci Rep; 2022 Dec; 12(1):21724. PubMed ID: 36522357
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of presepsin in preterm deliveries.
Malíčková K; Koucký M; Pařízek A; Pelinková K; Brodská H; Hájek Z; Germanová A; Mestek O; Zima T
J Matern Fetal Neonatal Med; 2015 Jun; 28(9):1032-7. PubMed ID: 25001428
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated soluble CD14 stabilization prevents agitation-induced increases in presepsin levels in blood component specimens.
Morino G; Takahashi G; Kan S; Inoue Y; Sato K; Shirakawa K
Biotechniques; 2021 Mar; 70(3):160-166. PubMed ID: 33512240
[TBL] [Abstract][Full Text] [Related]
14. Presepsin as a predictor of critical colonization in CLI hemodialysis patients.
Shiota J; Ohura N; Higashikawa S; Yamato T; Kasahara H; Itatani K; Tagawa H
Wound Repair Regen; 2016; 24(1):189-94. PubMed ID: 26464025
[TBL] [Abstract][Full Text] [Related]
15. A rapid and quantitative D-Dimer assay in whole blood and plasma on the point-of-care PATHFAST analyzer.
Fukuda T; Kasai H; Kusano T; Shimazu C; Kawasugi K; Miyazawa Y
Thromb Res; 2007; 120(5):695-701. PubMed ID: 17316774
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure].
Galeano D; Zanoli L; Fatuzzo P; Granata A
G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067215
[TBL] [Abstract][Full Text] [Related]
18. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.
Sargentini V; Ceccarelli G; D'Alessandro M; Collepardo D; Morelli A; D'Egidio A; Mariotti S; Nicoletti AM; Evangelista B; D'Ettorre G; Angeloni A; Venditti M; Bachetoni A
Clin Chem Lab Med; 2015 Mar; 53(4):567-73. PubMed ID: 24897401
[TBL] [Abstract][Full Text] [Related]
19. Pathfast presepsin assay for early diagnosis of bacterial infections in surgical patients: preliminary study.
Novelli G; Morabito V; Ferretti G; Pugliese F; Ruberto F; Venuta F; Poli L; Rossi M; Berloco PB
Transplant Proc; 2013 Sep; 45(7):2750-3. PubMed ID: 24034039
[TBL] [Abstract][Full Text] [Related]
20. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
